Nifty

:

14371.90

Sensex

:

48878.54

-218.45 (-1.50%)
-746.22 (-1.50%)

Login

Nifty
Sensex

:
:

14371.90
48878.54

-218.45 (-1.50%)
-746.22 (-1.50%)

Wintac Ltd.

Pharmaceuticals & Drugs

Rating :

70/99

BSE: 524758 | NSE: Not Listed

Watchlist

NSE BSE

Not traded in the last 30 days

Open
High
Low
Previous Close

N/A
N/A
N/A
N/A

Volume
Traded Value (lacs)
52 Week High
52 Week Low

N/A
N/A
N/A
N/A

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

342.43
194.45
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

369.54
N/A
-54.47

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.30
36.29
24.27

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.49
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-27.36
-32.13

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-26.32
-26.32
-26.32

EV:EBITDA (Average)

8 Years
5 Years
3 Years

35.56
48.29
86.69

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 44.92 17.57 155.66% 30.04 17.82 68.57% 29.19 25.27 15.51% 20.53 19.38 5.93%
Expenses 40.31 19.51 106.61% 27.35 16.99 60.98% 25.54 20.00 27.70% 20.30 13.30 52.63%
EBITDA 4.61 -1.94 - 2.70 0.83 225.30% 3.64 5.27 -30.93% 0.23 6.08 -96.22%
EBIDTM 10.27% -11.04% 8.98% 4.66% -0.29% -0.29% 1.14% 31.38%
Other Income 0.06 0.03 100.00% 0.05 0.16 -68.75% 1.44 0.78 84.62% 1.13 0.66 71.21%
Interest 0.62 0.42 47.62% 0.62 0.10 520.00% 0.68 0.10 580.00% 0.72 0.05 1,340.00%
Depreciation 2.31 1.56 48.08% 2.26 1.35 67.41% 2.22 1.15 93.04% 2.10 1.06 98.11%
PBT 1.74 -3.89 - -0.13 -0.47 - 2.19 4.80 -54.38% -1.46 5.62 -
Tax 0.27 -0.55 - 0.18 -0.14 - 0.95 0.40 137.50% -0.82 -0.27 -
PAT 1.47 -3.34 - -0.32 -0.32 - 1.24 4.40 -71.82% -0.64 5.88 -
PATM 3.28% -19.02% -1.05% -1.81% 2.87% 2.87% -3.09% 30.37%
EPS 1.47 -3.34 - -0.32 -0.32 - 1.24 4.40 -71.82% -0.64 5.88 -

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 124.68 85.11 71.92 44.35 32.80 18.10 29.47 30.48 20.88 24.27 26.67 Net Sales Growth 55.77% 18.34% 62.16% 35.21% 81.22% -38.58% -3.31% 45.98% -13.97% -9.00% Cost Of Goods Sold 533.85 13.11 8.09 8.54 8.78 5.29 6.73 7.33 4.11 6.45 5.36 Gross Profit -409.17 72.00 63.82 35.82 24.02 12.80 22.74 23.14 16.77 17.82 21.31 GP Margin -328.17% 84.60% 88.74% 80.77% 73.23% 70.72% 77.16% 75.92% 80.32% 73.42% 79.90% Total Expenditure 113.50 82.34 77.98 50.32 40.47 31.43 31.39 31.91 23.93 24.62 21.80 Power & Fuel Cost - 8.36 5.70 4.39 4.08 3.19 3.38 3.51 2.97 2.87 2.44 % Of Sales - 9.82% 7.93% 9.90% 12.44% 17.62% 11.47% 11.52% 14.22% 11.83% 9.15% Employee Cost - 27.69 23.25 18.22 15.03 12.88 11.26 9.59 7.94 7.49 6.46 % Of Sales - 32.53% 32.33% 41.08% 45.82% 71.16% 38.21% 31.46% 38.03% 30.86% 24.22% Manufacturing Exp. - 26.16 21.99 12.98 8.07 6.59 6.13 7.21 4.97 5.60 4.41 % Of Sales - 30.74% 30.58% 29.27% 24.60% 36.41% 20.80% 23.65% 23.80% 23.07% 16.54% General & Admin Exp. - 3.28 2.78 5.08 3.39 2.16 2.83 3.18 2.44 1.40 1.24 % Of Sales - 3.85% 3.87% 11.45% 10.34% 11.93% 9.60% 10.43% 11.69% 5.77% 4.65% Selling & Distn. Exp. - 0.15 0.12 0.08 0.06 0.12 0.10 0.19 0.35 0.27 0.36 % Of Sales - 0.18% 0.17% 0.18% 0.18% 0.66% 0.34% 0.62% 1.68% 1.11% 1.35% Miscellaneous Exp. - 3.60 16.04 1.03 1.06 1.19 0.96 0.89 1.16 0.53 0.36 % Of Sales - 4.23% 22.30% 2.32% 3.23% 6.57% 3.26% 2.92% 5.56% 2.18% 5.74% EBITDA 11.18 2.77 -6.06 -5.97 -7.67 -13.33 -1.92 -1.43 -3.05 -0.35 4.87 EBITDA Margin 8.97% 3.25% -8.43% -13.46% -23.38% -73.65% -6.52% -4.69% -14.61% -1.44% 18.26% Other Income 2.68 2.76 11.38 0.72 1.44 0.18 0.14 0.63 0.35 0.25 0.10 Interest 2.64 1.91 0.93 0.90 1.00 0.94 0.15 0.29 2.82 3.00 2.50 Depreciation 8.89 7.24 4.18 3.55 3.63 3.87 3.64 1.88 1.94 1.96 1.71 PBT 2.34 -3.62 0.21 -9.70 -10.86 -17.95 -5.56 -2.98 -7.46 -5.07 0.76 Tax 0.58 -0.56 0.10 0.09 -1.21 -1.21 -1.51 0.52 -0.58 0.31 -0.02 Tax Rate 24.79% 15.47% 47.62% -0.93% 12.51% 7.41% 19.71% -8.04% 3.26% -6.10% -2.63% PAT 1.75 -3.06 0.11 -9.79 -8.46 -15.13 -6.15 -6.99 -17.20 -5.38 0.78 PAT before Minority Interest 1.75 -3.06 0.11 -9.79 -8.46 -15.13 -6.15 -6.99 -17.20 -5.38 0.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.40% -3.60% 0.15% -22.07% -25.79% -83.59% -20.87% -22.93% -82.38% -22.17% 2.92% PAT Growth -73.56% - - - - - - - - - EPS 1.75 -3.06 0.11 -9.79 -8.46 -15.13 -6.15 -6.99 -17.20 -5.38 0.78

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds -8.17 -4.38 -4.22 5.67 14.12 29.25 35.40 44.40 21.60 23.08 Share Capital 10.02 10.02 10.02 10.02 10.03 10.03 10.03 12.03 8.03 7.54 Total Reserves -18.19 -14.41 -14.25 -4.35 4.09 19.22 25.37 32.37 13.57 15.54 Non-Current Liabilities 17.59 8.60 -0.32 -0.05 3.07 -4.08 -2.18 -2.10 5.47 4.42 Secured Loans 0.00 0.00 5.44 6.41 8.29 0.00 0.00 0.00 5.73 5.50 Unsecured Loans 21.28 13.78 0.00 0.00 0.00 0.00 0.39 0.97 2.22 1.71 Long Term Provisions 3.45 1.12 0.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 144.83 125.46 70.81 45.96 30.59 20.25 15.91 15.31 23.15 25.06 Trade Payables 13.20 12.65 4.75 6.25 5.83 5.20 7.91 6.51 5.95 6.33 Other Current Liabilities 128.45 61.49 64.69 38.18 23.70 14.34 7.62 7.36 8.68 8.25 Short Term Borrowings 2.38 50.17 0.00 0.25 0.25 0.00 0.00 1.25 7.98 10.01 Short Term Provisions 0.80 1.16 1.38 1.28 0.81 0.71 0.38 0.19 0.54 0.48 Total Liabilities 154.25 129.68 66.27 51.58 47.78 45.42 49.13 57.61 50.22 52.56 Net Block 106.55 51.61 31.23 31.67 31.51 31.69 29.89 22.44 24.81 23.99 Gross Block 124.87 62.84 38.40 35.29 56.18 52.49 47.42 38.00 41.09 38.31 Accumulated Depreciation 18.31 11.23 7.17 3.62 24.67 20.80 17.52 15.57 16.28 14.32 Non Current Assets 109.71 97.72 46.32 34.02 36.67 36.12 34.05 27.79 38.74 36.63 Capital Work in Progress 1.41 39.31 6.13 0.05 2.45 0.01 0.00 2.10 1.50 0.73 Non Current Investment 0.00 0.43 0.43 0.00 0.00 0.00 0.00 0.00 0.90 0.90 Long Term Loans & Adv. 1.60 5.41 7.57 2.30 0.68 1.98 1.88 1.85 10.27 10.29 Other Non Current Assets 0.15 0.96 0.96 0.00 2.03 2.44 2.28 1.40 1.25 0.72 Current Assets 44.54 31.96 19.95 17.57 11.10 9.30 15.08 29.82 11.49 15.94 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 25.32 19.45 9.04 7.86 6.52 4.85 6.25 4.64 4.90 5.58 Sundry Debtors 3.10 1.92 0.80 3.63 2.92 2.48 5.75 3.68 4.28 7.66 Cash & Bank 1.35 0.06 0.54 0.01 0.30 0.42 0.61 17.84 1.32 1.41 Other Current Assets 14.77 3.41 6.04 5.69 1.36 1.54 2.48 3.66 0.99 1.28 Short Term Loans & Adv. 1.01 7.13 3.54 0.38 0.67 0.64 1.69 0.65 0.51 0.03 Net Current Assets -100.29 -93.50 -50.86 -28.40 -19.49 -10.95 -0.83 14.51 -11.67 -9.12 Total Assets 154.25 129.68 66.27 51.59 47.77 45.42 49.13 57.61 50.23 52.57

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 60.44 -4.08 18.20 4.25 -3.90 6.03 -6.50 -3.01 3.85 3.46 PBT -3.62 0.21 -9.70 -9.67 -16.34 -7.67 -6.47 -17.78 -5.08 0.81 Adjustment 7.42 4.92 4.24 4.55 5.07 5.59 1.45 14.64 4.85 4.12 Changes in Working Capital 56.77 -9.18 23.66 9.37 7.37 8.10 -1.48 0.13 4.08 -1.47 Cash after chg. in Working capital 60.56 -4.05 18.20 4.25 -3.90 6.03 -6.50 -3.01 3.85 3.46 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.12 -0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -20.47 -55.54 -15.54 -1.72 -4.82 -5.53 -7.05 -0.49 -3.58 -6.43 Net Fixed Assets -24.13 -57.62 -9.19 23.29 -6.13 -5.08 -7.32 2.49 -3.55 -5.55 Net Investments 0.43 0.00 -0.43 0.00 0.00 0.00 0.00 0.90 0.00 0.00 Others 3.23 2.08 -5.92 -25.01 1.31 -0.45 0.27 -3.88 -0.03 -0.88 Cash from Financing Activity -40.02 59.15 -2.13 -2.81 8.63 -0.70 -3.68 20.01 -0.36 3.64 Net Cash Inflow / Outflow -0.05 -0.47 0.53 -0.29 -0.08 -0.20 -17.23 16.51 -0.09 0.66 Opening Cash & Equivalents 0.06 0.54 0.01 0.30 0.38 0.58 17.81 1.32 1.41 0.75 Closing Cash & Equivalent 0.01 0.06 0.54 0.01 0.30 0.38 0.58 17.84 1.32 1.41

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) -8.15 -4.37 -4.21 5.66 14.08 29.17 35.31 42.29 32.52 42.01 ROA -2.16% 0.11% -16.62% -17.03% -32.48% -13.02% -13.11% -31.90% -10.47% 1.66% ROE 0.00% 0.00% -1348.73% -85.52% -69.81% -19.04% -17.98% -55.50% -27.14% 4.28% ROCE -4.15% 3.54% -109.91% -46.39% -57.64% -22.79% -14.61% -33.55% -4.93% 8.45% Fixed Asset Turnover 0.90 1.42 1.22 0.76 0.37 0.61 0.77 0.57 0.65 0.77 Receivable days 10.75 6.89 18.02 34.22 49.03 49.13 52.66 64.07 84.03 88.10 Inventory Days 96.00 72.29 68.87 75.25 103.23 66.22 60.77 76.76 73.78 54.42 Payable days 57.20 48.98 41.58 55.22 63.09 80.53 84.89 101.42 89.53 79.79 Cash Conversion Cycle 49.56 30.19 45.30 54.25 89.17 34.82 28.53 39.42 68.28 62.73 Total Debt/Equity -3.48 -15.17 -1.59 1.39 0.69 0.01 0.03 0.09 0.90 0.88 Interest Cover -0.89 1.22 -9.79 -8.70 -16.40 -49.97 -21.13 -5.30 -0.69 1.30

Top Investors:

bangalore pharmaceutical and research laboratory pvt ltd

sural thammaiah raghavendra mady

s jayaprakash mady

Annual Reports:

News Update:

Wintac to consider borrowing of funds upto Rs 750 crore
1st Dec 2020, 11:00 AM

A meeting of the Board of Directors of the company has been scheduled on December 03, 2020 to consider, the proposal for borrowing of funds
Read More
Wintac - Quarterly Results
12th Nov 2020, 18:04 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback